Niagen Bioscience, Inc. (NAGE) Operating income 2016–2025
Niagen Bioscience, Inc. (NAGE) annual operating income history from SEC filings — each fiscal year as reported.
$16.3MFY2025 · since FY2016: -$2.9M → $16.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $16.3M | +110.7% |
| FY2024 | $7.7M | +238.0% |
| FY2023 | -$5.6M | +69.9% |
| FY2022 | -$18.6M | +31.2% |
| FY2021 | -$27.1M | -36.4% |
| FY2020 | -$19.9M | +36.6% |
| FY2019 | -$31.3M | +5.6% |
| FY2018 | -$33.2M | -102.6% |
| FY2017 | -$16.4M | -463.7% |
| FY2016 | -$2.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice